- Home
- ARWR vs NMIH Comparison
ARWR vs NMIH Comparison
Compare ARWR & NMIH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ARWR | NMIH |
|---|---|---|
| Founded | 2003 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Property-Casualty Insurers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.4B | 2.8B |
| IPO Year | 2009 | 2013 |
Fundamental Metrics
Financial Performance| Metric | ARWR | NMIH |
|---|---|---|
| Price | $86.83 | $45.71 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 10 | 4 |
| Target Price | ★ $83.40 | $43.25 |
| AVG Volume (30 Days) | ★ 1.9M | 443.6K |
| Earning Date | 05-07-2026 | 04-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 99.80 | 11.06 |
| EPS | N/A | ★ 2.66 |
| Revenue | $16,142,321.00 | ★ $706,440,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $4.34 |
| P/E Ratio | ★ N/A | $17.08 |
| Revenue Growth | N/A | ★ 8.52 |
| 52 Week Low | $19.42 | $34.84 |
| 52 Week High | $95.49 | $46.74 |
Technical Indicators
Market Signals| Indicator | ARWR | NMIH |
|---|---|---|
| Relative Strength Index (RSI) | 54.71 | 67.98 |
| Support Level | $70.03 | $36.12 |
| Resistance Level | $87.83 | $46.74 |
| Average True Range (ATR) | 3.31 | 1.17 |
| MACD | -0.19 | -0.00 |
| Stochastic Oscillator | 55.29 | 68.09 |
Price Performance
Historical ComparisonAbout ARWR Arrowhead Pharmaceuticals Inc.
Arrowhead Pharmaceuticals Inc is a commercial-stage pharmaceutical company. It is focused on the development of medicines for diseases associated with genetic abnormalities or protein overproduction. The company develops potential RNAi therapies designed to inhibit the expression of genes known to trigger diseases. Its portfolio includes potential drugs targeting Cardiometabolic, Neuromuscular, Pulmonary, Liver, and other diseases. The company also develops RNAi products and clinical candidates designed to target different cell types within the body.
About NMIH NMI Holdings Inc.
NMI Holdings Inc through its subsidiaries provides private mortgage guaranty insurance. The company offers mortgage insurance, reinsurance on loans, and outsourced loan review services to mortgage loan originators. It serves national and regional mortgage banks, money center banks, credit unions, community banks, builder-owned mortgage lenders, Internet-sourced lenders, and other non-bank lenders. It protects lenders and investors from default-related losses on a portion of the unpaid principal balance of a covered mortgage.